Inflammatory bowel disease: Clinical screening and transition of care

Inflammatory bowel disease (IBD), a chronic immunemediated disorder encompassing Crohn’s disease and ulcerative colitis, has the highest prevalence in North America and Europe.[1] The incidence of IBD, however, has been increasing in low prevalence regions such as Asia and the Middle East.[2] The Kingdom of Saudi Arabia (KSA) is one region where this pattern has been noted and described.[3-5] The increase in incidence and prevalence of IBD in this region highlights the importance of early recognition and accurate diagnosis.